{"DataElement":{"publicId":"5628445","version":"1","preferredName":"Sorafenib Administered Month Count","preferredDefinition":"The number of months that sorafenib was administered.","longName":"2867291v1.0:2497191v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2867291","version":"1","preferredName":"Sorafenib Administered","preferredDefinition":"A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis._The act of having given something (e.g., a medication or test).","longName":"2867289v1.0:2233610v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2867289","version":"1","preferredName":"Sorafenib","preferredDefinition":"A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.","longName":"C61948","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sorafenib","conceptCode":"C61948","definition":"A synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"692F9FF7-B8D3-8A4A-E040-BB89AD435BBE","latestVersionIndicator":"Yes","beginDate":"2009-05-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-05-05","modifiedBy":"ONEDATA","dateModified":"2009-05-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"692F9FF7-B8E1-8A4A-E040-BB89AD435BBE","latestVersionIndicator":"Yes","beginDate":"2009-05-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-05-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2497191","version":"1","preferredName":"Month Count","preferredDefinition":"the numeric count of months.","longName":"MON_CT","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2524751","version":"1","preferredName":"Month Count","preferredDefinition":"One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.:To determine the number or amount of something; the result of this activity.","longName":"C29846:C25463","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Month","conceptCode":"C29846","definition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1ED97F94-CC7D-750A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-02","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-10-02","modifiedBy":"ONEDATA","dateModified":"2006-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"18E11A1C-4289-5A55-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-07-18","modifiedBy":"CAMPBELB","dateModified":"2008-03-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"10115208","version":"1","longName":"QA Test CS","context":"TEST","ClassificationSchemeItems":[{"publicId":"10115209","version":"1","longName":"QA Test CSI","context":"TEST"}]}],"AlternateNames":[{"name":"AMLP_LTHM_sor_therap_month_ct","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What were the number of month","type":"Preferred Question Text","description":"What were the number of months that sorafenib was administered?","url":null,"context":"NHLBI"},{"name":"Specify months of therapy:","type":"Alternate Question Text","description":"Specify months of therapy:","url":null,"context":"NHLBI"},{"name":"Specify months of therapy:","type":"Application Standard Question Text","description":"Specify months of therapy:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"463AC4B6-6D92-4959-E053-F662850A7C6C","latestVersionIndicator":"Yes","beginDate":"2017-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-16","modifiedBy":"CCURATOR","dateModified":"2022-04-30","changeDescription":"System generated def displayed as alt def..released 8/29/17mn.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}